The North America Pharmaceutical Drug Delivery Market would witness market growth of 3.4% CAGR during the forecast period (2023-2030).
Controlled-release drug delivery systems offer a sustained and prolonged release of medications over an extended period. This reduces the frequency of administration and helps maintain therapeutic drug levels in the bloodstream. Extended-release formulations are commonly used for chronic conditions, such as pain management, where around-the-clock relief is desired. The administration of chronic diseases, including diabetes, cardiovascular disease, and autoimmune disorders, depends heavily on drug delivery technology. Continuous and controlled drug delivery is essential for maintaining optimal therapeutic levels. Insulin pumps, transdermal patches, and inhalation devices are examples of drug delivery systems designed for the long-term management of chronic conditions.
The advent of biologics and gene therapies has spurred advancements in drug delivery to ensure the effective administration of these complex molecules. Nanoparticle-based carriers and specialized delivery platforms protect biologics from degradation and facilitate targeted delivery to specific cells or tissues. Drug delivery systems are adapted to meet pediatric and geriatric populations' unique needs. Pediatric formulations may involve flavored liquids or oral dissolvable films, while geriatric patients may benefit from simplified dosing regimens or controlled-release formulations. Drug delivery technologies are utilized to overcome the blood-brain barrier and enhance the delivery of medications to the central nervous system. This is crucial for the treatment of neurological disorders, such as Alzheimer’s disease and Parkinson’s disease.
According to the Centers for Disease Control and Prevention, six out of ten Americans suffer from at least one chronic condition, including diabetes, cancer, heart disease, or a stroke. The leading causes of death and disability in the US are these and other chronic disorders, dramatically raising healthcare costs. The aging population in America is more susceptible to chronic diseases. Many individuals in America are managing multiple chronic conditions simultaneously. Hence, the factors mentioned above will drive the regional market growth.
The US market dominated the North America Pharmaceutical Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $513.7 Billion by 2030. The Canada market is experiencing a CAGR of 5.8% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 4.8% during (2023 - 2030).
Free Valuable Insights: The Pharmaceutical Drug Delivery Market is Predict to reach $1.9 Trillion by 2030, at a CAGR of 4.1%
Based on Route of Administration, the market is segmented into Injectable Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery, and Ocular Drug Delivery. Based on Application, the market is segmented into Respiratory & Other Diseases, Cancer, Diabetes, and Cardiovascular Diseases. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- F.Hoffmann-La Roche Ltd.
- Bayer AG
- Pfizer, Inc.
- Johnson & Johnson
- Novartis AG
- Amgen, Inc.
- Sanofi S.A.
- Cipla Limited
- Merck & Co., Inc.
North America Pharmaceutical Drug Delivery Market Report Segmentation
By Route of Administration
- Injectable Drug Delivery
- Oral Drug Delivery
- Topical Drug Delivery
- Nasal Drug Delivery
- Ocular Drug Delivery
By Application
- Respiratory & Other Diseases
- Cancer
- Diabetes
- Cardiovascular Diseases
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pharmaceutical Drug Delivery Market, by Route of Administration
1.4.2 North America Pharmaceutical Drug Delivery Market, by Application
1.4.3 North America Pharmaceutical Drug Delivery Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.2.5 Trials & Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2021-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2021, Aug – 2023, Oct) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Pharmaceutical Drug Delivery Market, by Route of Administration
5.1 North America Injectable Drug Delivery Market, by Country
5.2 North America Oral Drug Delivery Market, by Country
5.3 North America Topical Drug Delivery Market, by Country
5.4 North America Nasal Drug Delivery Market, by Country
5.5 North America Ocular Drug Delivery Market, by Country
Chapter 6. North America Pharmaceutical Drug Delivery Market, by Application
6.1 North America Respiratory & Other Diseases Market, by Country
6.2 North America Cancer Market, by Country
6.3 North America Diabetes Market, by Country
6.4 North America Cardiovascular Diseases Market, by Country
Chapter 7. North America Pharmaceutical Drug Delivery Market, by Country
7.1 US Pharmaceutical Drug Delivery Market
7.1.1 US Pharmaceutical Drug Delivery Market, by Route of Administration
7.1.2 US Pharmaceutical Drug Delivery Market, by Application
7.2 Canada Pharmaceutical Drug Delivery Market
7.2.1 Canada Pharmaceutical Drug Delivery Market, by Route of Administration
7.2.2 Canada Pharmaceutical Drug Delivery Market, by Application
7.3 Mexico Pharmaceutical Drug Delivery Market
7.3.1 Mexico Pharmaceutical Drug Delivery Market, by Route of Administration
7.3.2 Mexico Pharmaceutical Drug Delivery Market, by Application
7.4 Rest of North America Pharmaceutical Drug Delivery Market
7.4.1 Rest of North America Pharmaceutical Drug Delivery Market, by Route of Administration
7.4.2 Rest of North America Pharmaceutical Drug Delivery Market, by Application
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Trials & Approvals:
8.2.6 SWOT Analysis
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Johnson & Johnson
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental & Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Novartis AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 Cipla Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis
TABLE 1 North America Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 2 North America Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 3 Partnerships, Collaborations and Agreements– Pharmaceutical Drug Delivery Market
TABLE 4 Product Launches And Product Expansions– Pharmaceutical Drug Delivery Market
TABLE 5 Acquisition and Mergers– Pharmaceutical Drug Delivery Market
TABLE 6 Geographical expansions– Pharmaceutical Drug Delivery Market
TABLE 7 Trials & Approvals– Pharmaceutical Drug Delivery Market
TABLE 8 North America Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 9 North America Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 10 North America Injectable Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 11 North America Injectable Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 12 North America Oral Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 13 North America Oral Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 14 North America Topical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 15 North America Topical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 16 North America Nasal Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 17 North America Nasal Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 18 North America Ocular Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 19 North America Ocular Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 20 North America Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 21 North America Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 22 North America Respiratory & Other Diseases Market, by Country, 2019 - 2022, USD Billion
TABLE 23 North America Respiratory & Other Diseases Market, by Country, 2023 - 2030, USD Billion
TABLE 24 North America Cancer Market, by Country, 2019 - 2022, USD Billion
TABLE 25 North America Cancer Market, by Country, 2023 - 2030, USD Billion
TABLE 26 North America Diabetes Market, by Country, 2019 - 2022, USD Billion
TABLE 27 North America Diabetes Market, by Country, 2023 - 2030, USD Billion
TABLE 28 North America Cardiovascular Diseases Market, by Country, 2019 - 2022, USD Billion
TABLE 29 North America Cardiovascular Diseases Market, by Country, 2023 - 2030, USD Billion
TABLE 30 North America Pharmaceutical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
TABLE 31 North America Pharmaceutical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
TABLE 32 US Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 33 US Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 34 US Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 35 US Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 36 US Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 37 US Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 38 Canada Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 39 Canada Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 40 Canada Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 41 Canada Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 42 Canada Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 43 Canada Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 44 Mexico Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 45 Mexico Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 46 Mexico Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 47 Mexico Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 48 Mexico Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 49 Mexico Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 50 Rest of North America Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
TABLE 51 Rest of North America Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
TABLE 52 Rest of North America Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
TABLE 53 Rest of North America Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
TABLE 54 Rest of North America Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
TABLE 55 Rest of North America Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
TABLE 56 Key Information – GlaxoSmithKline PLC
TABLE 57 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 58 Key Information – Bayer AG
TABLE 59 Key Information – Pfizer, Inc.
TABLE 60 Key Information – Johnson & Johnson
TABLE 61 Key Information – Novartis AG
TABLE 62 Key Information – Amgen, Inc.
TABLE 63 Key Information – Sanofi S.A.
TABLE 64 Key Information – Cipla Limited
TABLE 65 Key Information - Merck & Co., Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Pharmaceutical Drug Delivery Market, 2019 - 2030, USD Billion
FIG 3 Key Factors Impacting Pharmaceutical Drug Delivery Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2021-2024)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2021, Aug – 2023, Oct) Leading Players
FIG 7 Porter’s Five Forces Analysis - Pharmaceutical Drug Delivery Market
FIG 8 North America Pharmaceutical Drug Delivery Market share, by Route of Administration, 2022
FIG 9 North America Pharmaceutical Drug Delivery Market share, by Route of Administration, 2030
FIG 10 North America Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2030, USD Billion
FIG 11 North America Pharmaceutical Drug Delivery Market share, by Application, 2022
FIG 12 North America Pharmaceutical Drug Delivery Market share, by Application, 2030
FIG 13 North America Pharmaceutical Drug Delivery Market, by Application, 2019 - 2030, USD Billion
FIG 14 North America Pharmaceutical Drug Delivery Market share, by Country, 2022
FIG 15 North America Pharmaceutical Drug Delivery Market share, by Country, 2030
FIG 16 North America Pharmaceutical Drug Delivery Market, by Country, 2019 - 2030, USD Billion
FIG 17 Recent strategies and developments: GlaxoSmithKline PLC (GSK)
FIG 18 SWOT Analysis: GlaxoSmithKline PLC
FIG 19 Recent strategies and developments: F. Hoffmann-La Roche Ltd
FIG 20 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 21 Recent strategies and developments: Bayer Ag
FIG 22 Swot Analysis: Bayer AG
FIG 23 SWOT Analysis: Pfizer, Inc.
FIG 24 Recent strategies and developments: Johnson & Johnson
FIG 25 SWOT Analysis: Johnson & Johnson
FIG 26 Recent strategies and developments: NOVARTIS AG
FIG 27 SWOT Analysis: Novartis AG
FIG 28 Swot Analysis: Amgen, Inc.
FIG 29 Recent strategies and developments: Sanofi S.a.
FIG 30 Swot Analysis: Sanofi S.A.
FIG 31 SWOT Analysis: Cipla Limited
FIG 32 SWOT Analysis: Merck & Co., Inc.